Louisa Shaw-Marotto
Nessuna posizione attualmente
Profilo
Louisa Shaw-Marotto served as Vice Chairman-Supervisory Board at Valneva SE from 2016 to 2020.
Prior to that, she was Vice President-Marketing at Merck & Co., Inc. from 2010 to 2013.
She also served as President at Executive Perspective Consulting LLC from 2014 to 2019.
In 2019, she briefly served as Vice President-Medical Affairs at The Medicines Co. Ms. Shaw-Marotto completed her undergraduate degree at the University of Technology Sydney.
Precedenti posizioni note di Louisa Shaw-Marotto
| Società | Posizione | Fine |
|---|---|---|
| VALNEVA | Direttore/Membro del Consiglio | 17/06/2020 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01/04/2020 |
Executive Perspective Consulting LLC
 Executive Perspective Consulting LLC Miscellaneous Commercial ServicesCommercial Services Executive Perspective Consulting LLC provides business consulting services. The private company is based in River Edge. | Presidente | 01/06/2019 |
| MERCK & CO., INC. | Vendite & Marketing | 01/12/2013 |
Formazione di Louisa Shaw-Marotto
| University of Technology Sydney | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VALNEVA | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Executive Perspective Consulting LLC
Executive Perspective Consulting LLC Miscellaneous Commercial ServicesCommercial Services Executive Perspective Consulting LLC provides business consulting services. The private company is based in River Edge. | Commercial Services |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- Louisa Shaw-Marotto
